<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Peng S</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>UC Davis Center for Equine Health</funding><funding>Southern California Equine Foundation</funding><pagination>2203-2212</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9708438</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Increases in serum gamma-glutamyltransferase (GGT) activity have been reported in Thoroughbred (TB) racehorses and associated with maladaptation to training but the underlying etiology remains unknown.&lt;h4>Hypothesis/objectives&lt;/h4>Classify the etiology of high GGT syndrome in racing TBs by assessment of pancreatic enzymes, vitamin E concentrations, and both a candidate gene and whole genome association study. We hypothesized that a genetic variant resulting in antioxidant insufficiency or pancreatic dysfunction would be responsible for high GGT syndrome in TBs.&lt;h4>Animals&lt;/h4>A total of 138 California racing TBs. Amylase: n = 31 affected (serum GGT activity ≥60 IU/L), n = 52 control (serum GGT activity &lt;40 IU/L). Lipase: n = 19 affected, n = 35 control. Serum α-tocopherol concentrations: n = 32 affected, n = 46 control. Genome-wide association study (GWAS): 36 affected, 58 control. Whole genome sequencing: n = 5 affected, n = 5 control.&lt;h4>Methods&lt;/h4>Biochemical and vitamin analytes were compared among cohorts. A GWAS was performed and a subset of TBs underwent whole genome sequencing to interrogate candidate genes and positional genetic regions.&lt;h4>Results&lt;/h4>Serum lipase and amylase activity and α-tocopherol concentrations did not differ between groups. No genetic variants were identified in 2 candidate genes (UGT1A1 and GGT1) that associated with the phenotype. Four single nucleotide polymorphisms (SNPs) approached a suggestive association with the phenotype (P = 2.15 × 10&lt;sup>-5&lt;/sup> ), defining a 100 kb region on chromosome 5 surrounding cluster of differentiation 1a (CD1A1), a transmembrane gene related to the major histocompatibility complex.&lt;h4>Conclusions and clinical importance&lt;/h4>An underlying genetic etiology may exist for high GGT syndrome in racing TBs, similar to genetic disorders in humans.</pubmed_abstract><journal>Journal of veterinary internal medicine</journal><pubmed_title>Investigation of high gamma-glutamyltransferase syndrome in California Thoroughbred racehorses.</pubmed_title><pmcid>PMC9708438</pmcid><funding_grant_id>L40 TR001136</funding_grant_id><funding_grant_id>NA</funding_grant_id><pubmed_authors>Blea J</pubmed_authors><pubmed_authors>Magdesian KG</pubmed_authors><pubmed_authors>Carpenter R</pubmed_authors><pubmed_authors>Peng S</pubmed_authors><pubmed_authors>Ho W</pubmed_authors><pubmed_authors>Finno CJ</pubmed_authors><pubmed_authors>Dowd J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Investigation of high gamma-glutamyltransferase syndrome in California Thoroughbred racehorses.</name><description>&lt;h4>Background&lt;/h4>Increases in serum gamma-glutamyltransferase (GGT) activity have been reported in Thoroughbred (TB) racehorses and associated with maladaptation to training but the underlying etiology remains unknown.&lt;h4>Hypothesis/objectives&lt;/h4>Classify the etiology of high GGT syndrome in racing TBs by assessment of pancreatic enzymes, vitamin E concentrations, and both a candidate gene and whole genome association study. We hypothesized that a genetic variant resulting in antioxidant insufficiency or pancreatic dysfunction would be responsible for high GGT syndrome in TBs.&lt;h4>Animals&lt;/h4>A total of 138 California racing TBs. Amylase: n = 31 affected (serum GGT activity ≥60 IU/L), n = 52 control (serum GGT activity &lt;40 IU/L). Lipase: n = 19 affected, n = 35 control. Serum α-tocopherol concentrations: n = 32 affected, n = 46 control. Genome-wide association study (GWAS): 36 affected, 58 control. Whole genome sequencing: n = 5 affected, n = 5 control.&lt;h4>Methods&lt;/h4>Biochemical and vitamin analytes were compared among cohorts. A GWAS was performed and a subset of TBs underwent whole genome sequencing to interrogate candidate genes and positional genetic regions.&lt;h4>Results&lt;/h4>Serum lipase and amylase activity and α-tocopherol concentrations did not differ between groups. No genetic variants were identified in 2 candidate genes (UGT1A1 and GGT1) that associated with the phenotype. Four single nucleotide polymorphisms (SNPs) approached a suggestive association with the phenotype (P = 2.15 × 10&lt;sup>-5&lt;/sup> ), defining a 100 kb region on chromosome 5 surrounding cluster of differentiation 1a (CD1A1), a transmembrane gene related to the major histocompatibility complex.&lt;h4>Conclusions and clinical importance&lt;/h4>An underlying genetic etiology may exist for high GGT syndrome in racing TBs, similar to genetic disorders in humans.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-06-21T03:17:04.667Z</modification><creation>2025-04-07T06:21:26.167Z</creation></dates><accession>S-EPMC9708438</accession><cross_references><pubmed>36377652</pubmed><doi>10.1111/jvim.16582</doi></cross_references></HashMap>